Rocket Pharmaceuticals, Inc.

NasdaqGM:RCKT Voorraadrapport

Marktkapitalisatie: US$1.3b

Rocket Pharmaceuticals Eigendom

Wie zijn de grootste aandeelhouders en hebben insiders gekocht of verkocht?

Recente transacties met voorkennis

NasdaqGM:RCKT Recente transacties met voorkennis door bedrijven of personen
DatumWaardeNaamEntiteitRolAandelenMaximale prijs
21 Nov 24SellUS$144,782Gaurav ShahIndividual11,091US$13.05
21 Nov 24SellUS$15,338Martin WilsonIndividual1,175US$13.05
21 Nov 24SellUS$15,978John MilitelloIndividual1,224US$13.05
21 Nov 24SellUS$59,892Kinnari PatelIndividual4,588US$13.05
31 Oct 24SellUS$15,245John MilitelloIndividual917US$16.63
31 Oct 24SellUS$51,205Mark WhiteIndividual3,080US$16.63
16 Aug 24SellUS$73,812Kinnari PatelIndividual3,989US$18.50
16 Aug 24SellUS$19,004Martin WilsonIndividual1,027US$18.50
16 Aug 24SellUS$178,564Gaurav ShahIndividual9,650US$18.50
16 Aug 24SellUS$19,688John MilitelloIndividual1,064US$18.50
22 Jul 24SellUS$18,688John MilitelloIndividual812US$23.02
08 Jul 24SellUS$61,715Mark WhiteIndividual3,026US$20.40
16 May 24SellUS$24,471Martin WilsonIndividual1,048US$23.35
16 May 24SellUS$25,195John MilitelloIndividual1,079US$23.35
16 May 24SellUS$94,474Kinnari PatelIndividual4,046US$23.35
16 May 24SellUS$228,597Gaurav ShahIndividual9,790US$23.35
22 Apr 24SellUS$19,051John MilitelloIndividual833US$22.87
15 Apr 24SellUS$240,520David SouthwellIndividual10,000US$24.05
08 Apr 24SellUS$308,763Mark WhiteIndividual12,532US$24.64
21 Mar 24SellUS$69,979John MilitelloIndividual2,490US$28.10
21 Mar 24SellUS$7,790,943Simran Investment Group LlcCompany274,000US$28.43
29 Feb 24SellUS$120,257Martin WilsonIndividual4,100US$29.33
16 Feb 24SellUS$604,876Gaurav ShahIndividual20,272US$29.84
16 Feb 24SellUS$96,615John MilitelloIndividual3,238US$29.84
16 Feb 24SellUS$106,701Martin WilsonIndividual3,576US$29.84
16 Feb 24SellUS$212,805Kinnari PatelIndividual7,132US$29.84
22 Jan 24SellUS$17,356John MilitelloIndividual638US$27.20

Volume handel met voorkennis

Insider-aankopen: RCKT insiders hebben de afgelopen 3 maanden alleen aandelen verkocht.

Opsplitsing eigendom

Wat is de eigendomsstructuur van RCKT?
Type eigenaarAantal AandelenEigendomspercentage
Particuliere bedrijven104.9270,106%
Individuele insiders2.282.5312,31%
Hedgefondsen17.687.77217,9%
Instellingen78.580.28979,7%

Verwatering van aandelen: De aandeelhouders zijn het afgelopen jaar niet noemenswaardig verwaterd geweest.

Topaandeelhouders

Top 25 aandeelhouders bezitten 84.1% van het bedrijf
EigendomNaamAandelenHuidige waardeVerandering %Portefeuille %
19,4%
RTW Investments, LP
17.687.772US$249.6m0%3,35%
12,3%
Wellington Management Group LLP
11.242.144US$158.6m22,8%0,02%
6,99%
BlackRock, Inc.
6.370.721US$89.9m2,88%geen gegevens
6,07%
The Vanguard Group, Inc.
5.536.940US$78.1m-4,68%geen gegevens
4,93%
Westfield Capital Management Company, L.P.
4.493.833US$63.4m3,83%0,26%
4,52%
Maverick Capital, Ltd.
4.118.672US$58.1m4,85%1,04%
3,52%
T. Rowe Price Group, Inc.
3.207.781US$45.3m1,21%geen gegevens
3,4%
State Street Global Advisors, Inc.
3.102.022US$43.8m11,6%geen gegevens
2,36%
Citadel Advisors LLC
2.148.093US$30.3m-23,8%0,03%
2,08%
Janus Henderson Group plc
1.897.340US$26.8m-35%0,01%
1,77%
Geode Capital Management, LLC
1.617.866US$22.8m0,89%geen gegevens
1,63%
Frazier Life Sciences Management, LP
1.485.630US$21.0m-4,84%0,83%
1,61%
Tavistock Life Sciences
1.466.051US$20.7m0%1,31%
1,52%
Pictet Asset Management Limited
1.386.705US$19.6m13,1%0,02%
1,32%
Millennium Management LLC
1.202.495US$17.0m1.040%0,01%
1,22%
Gaurav Shah
1.113.566US$15.7m-0,99%geen gegevens
1,21%
Novo Holdings A/S
1.100.000US$15.5m0%0,01%
1,21%
Cowen Inc,Private Banking and Investment Banking Investments
1.100.000US$15.5m0%0,43%
1,17%
BioImpact Capital LLC
1.066.373US$15.0m0%2,36%
1,06%
Franklin Resources, Inc.
969.547US$13.7m-13,2%geen gegevens
1,02%
Perceptive Advisors LLC
931.851US$13.1m-25,3%0,28%
1%
Dimensional Fund Advisors LP
912.605US$12.9m-3,55%geen gegevens
0,97%
Baron Capital Group, Inc.
884.341US$12.5m-9,7%0,03%
0,89%
Russell Investment Management, LLC
812.310US$11.5m19,9%0,01%
0,89%
Medical Strategy GmbH, Asset Management Arm
808.816US$11.4m0%0,67%